RGLS RGLS

Regulus Therapeutics Stock Price

1.6894
-0.0406 (-2.35%)
Upgrade to Real-Time
Regular Market
1.6894
Volume 14,014
Bid Price 1.65
Ask Price 1.72
News -
Day High 1.7399

Low
0.1576

52 Week Range

High
2.4399

Day Low 1.66
Company Name Stock Ticker Symbol Market Type
Regulus Therapeutics Inc RGLS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0406 -2.35% 1.6894 10:20:37
Open Price Low Price High Price Close Price Prev Close
1.70 1.66 1.7399 1.73
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
41 14,014 $ 1.68 $ 23,611 - 0.1576 - 2.4399
Last Trade Time Type Quantity Stock Price Currency
10:18:27 140 $ 1.6894 USD

Period:

Draw Mode:

Regulus Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.72M 14.63M 11.11M $ - $ - -3.18 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.23M 41.00%

more financials information »

Regulus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RGLS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.691.83991.641.75113,414-0.0006-0.04%
1 Month1.881.961.421.69141,554-0.1906-10.14%
3 Months0.28772.43990.20120.5103399471,0681.40487.21%
6 Months0.222.43990.15760.29920181,374,4231.47667.91%
1 Year0.662.43990.15760.38093551,475,5291.03155.97%
3 Years0.56772.43990.15760.87843851,504,0361.12197.59%
5 Years9.9618.240.15762.021,130,839-8.27-83.04%

Regulus Therapeutics Description

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.


Your Recent History
NASDAQ
RGLS
Regulus Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now